Nano Dimension Completes First Sale of 3D printers and Nano Inks in India

Nano Dimension, a leading printing electronics company in the area of 3D printing, announced today that Nano Dimension Technologies, a fully owned subsidiary of Nano Dimension, has made its first sale of 3D printers and nano inks in India, totaling USD $250K.

The transaction was completed by Vigilante Environmental Solutions, Nano Dimension's business developer in India.

The agreement includes five "Dragonfly 2020" 3D Printers for Multilayered PCB that will be supplied during the second half of 2016 as well as 5Kg (~11 lbs.) of Conductive Nano Silver ink for industrial use, which will be supplied immediately as promotional samples. This development demonstrates Vigilante Environmental Solutions' strong relationships with India's industrial market and builds a foundation to promote Nano Dimension's ink products with prospective industrial customers in India as the company expands into this new territory.

Amit Dror, CEO of Nano Dimension, commented: "We are thrilled to report the company's first-ever sale of our pioneering 3D printer and inks. Our marketing and sales efforts to-date have been predominantly focused on our initial target markets, the U.S. and Israel, and the fact that the first sale is a result of our recently established relationship with Vigilante Environmental Solutions in India is a testament to the confidence our early partners have shown in the products we have developed. Their belief and positive feedback led to Nano's decision to expand into India. As we're able to report such a positive development in the market after a relatively short period of time, we expect this will continue to be a fruitful collaboration."

Source: http://www.nano-di.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.